| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hemoglobin beta binding | 6.91e-06 | 2 | 53 | 2 | GO:0031722 | |
| GeneOntologyMolecularFunction | hemoglobin alpha binding | 6.88e-05 | 5 | 53 | 2 | GO:0031721 | |
| GeneOntologyMolecularFunction | haptoglobin binding | 3.07e-04 | 10 | 53 | 2 | GO:0031720 | |
| GeneOntologyMolecularFunction | hemoglobin binding | 3.74e-04 | 11 | 53 | 2 | GO:0030492 | |
| GeneOntologyMolecularFunction | oxygen carrier activity | 6.16e-04 | 14 | 53 | 2 | GO:0005344 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 8.10e-04 | 16 | 53 | 2 | GO:0008179 | |
| GeneOntologyCellularComponent | haptoglobin-hemoglobin complex | 4.10e-04 | 12 | 53 | 2 | GO:0031838 | |
| GeneOntologyCellularComponent | hemoglobin complex | 4.10e-04 | 12 | 53 | 2 | GO:0005833 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 4.83e-04 | 13 | 53 | 2 | GO:0030877 | |
| GeneOntologyCellularComponent | Wnt signalosome | 7.40e-04 | 16 | 53 | 2 | GO:1990909 | |
| Domain | Haemoglobin_b | 7.86e-05 | 5 | 53 | 2 | IPR002337 | |
| Domain | Globin | 5.12e-04 | 12 | 53 | 2 | IPR000971 | |
| Domain | Globin | 5.12e-04 | 12 | 53 | 2 | PF00042 | |
| Domain | GLOBIN | 5.12e-04 | 12 | 53 | 2 | PS01033 | |
| Domain | - | 6.04e-04 | 13 | 53 | 2 | 1.10.490.10 | |
| Domain | Globin/Proto | 6.04e-04 | 13 | 53 | 2 | IPR012292 | |
| Domain | Globin-like | 9.24e-04 | 16 | 53 | 2 | IPR009050 | |
| Domain | MYB_LIKE | 5.20e-03 | 38 | 53 | 2 | PS50090 | |
| Domain | LAM_G_DOMAIN | 5.20e-03 | 38 | 53 | 2 | PS50025 | |
| Domain | SANT | 8.87e-03 | 50 | 53 | 2 | SM00717 | |
| Domain | SANT/Myb | 9.57e-03 | 52 | 53 | 2 | IPR001005 | |
| Pathway | REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE | 1.78e-04 | 9 | 32 | 2 | MM14530 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 2.22e-04 | 10 | 32 | 2 | M47486 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 3.25e-04 | 12 | 32 | 2 | M47410 | |
| Pathway | REACTOME_HEME_SIGNALING | 3.83e-04 | 13 | 32 | 2 | MM15685 | |
| Pathway | REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN | 3.83e-04 | 13 | 32 | 2 | MM14529 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 4.47e-04 | 14 | 32 | 2 | MM1459 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 4.47e-04 | 14 | 32 | 2 | M16173 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 5.15e-04 | 15 | 32 | 2 | MM1439 | |
| Pathway | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS | 5.15e-04 | 15 | 32 | 2 | M27407 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 5.87e-04 | 16 | 32 | 2 | M8516 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 6.65e-04 | 17 | 32 | 2 | M27083 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 6.65e-04 | 17 | 32 | 2 | M39525 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 6.65e-04 | 17 | 32 | 2 | MM1509 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 7.47e-04 | 18 | 32 | 2 | M31 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 7.47e-04 | 18 | 32 | 2 | MM14759 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 8.33e-04 | 19 | 32 | 2 | M18933 | |
| Pathway | PID_WNT_CANONICAL_PATHWAY | 9.25e-04 | 20 | 32 | 2 | M90 | |
| Pathway | BIOCARTA_GSK3_PATHWAY | 9.25e-04 | 20 | 32 | 2 | M11106 | |
| Pathway | BIOCARTA_GSK3_PATHWAY | 1.12e-03 | 22 | 32 | 2 | MM1421 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 1.23e-03 | 23 | 32 | 2 | MM1527 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 1.34e-03 | 24 | 32 | 2 | M16517 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 1.95e-03 | 29 | 32 | 2 | M39516 | |
| Pathway | PID_NECTIN_PATHWAY | 2.09e-03 | 30 | 32 | 2 | M72 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 2.23e-03 | 31 | 32 | 2 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 2.23e-03 | 31 | 32 | 2 | MM15154 | |
| Pathway | PID_NCADHERIN_PATHWAY | 2.52e-03 | 33 | 32 | 2 | M266 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 2.68e-03 | 34 | 32 | 2 | M27405 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 3.16e-03 | 37 | 32 | 2 | M47411 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 3.16e-03 | 37 | 32 | 2 | M17400 | |
| Pathway | WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING | 3.16e-03 | 37 | 32 | 2 | M39817 | |
| Pathway | PID_ECADHERIN_NASCENT_AJ_PATHWAY | 3.51e-03 | 39 | 32 | 2 | M156 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 3.69e-03 | 40 | 32 | 2 | MM15060 | |
| Pathway | PID_ECADHERIN_STABILIZATION_PATHWAY | 3.87e-03 | 41 | 32 | 2 | M232 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 4.45e-03 | 44 | 32 | 2 | MM15878 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 4.45e-03 | 44 | 32 | 2 | M27812 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 4.65e-03 | 45 | 32 | 2 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 4.85e-03 | 46 | 32 | 2 | M47409 | |
| Pathway | PID_PS1_PATHWAY | 4.85e-03 | 46 | 32 | 2 | M70 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 6086313 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22203977 | ||
| Pubmed | A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia. | 2.28e-06 | 2 | 53 | 2 | 16631345 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 37902616 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 270684 | ||
| Pubmed | Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. | 2.28e-06 | 2 | 53 | 2 | 21099112 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11121056 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 12480689 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 482942 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11830454 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11154217 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 14675418 | ||
| Pubmed | Nucleotide sequences of the mouse globin beta gene cDNAs in a wild derived new haplotype Hbb(w1). | 2.28e-06 | 2 | 53 | 2 | 10441738 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32344432 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 31562377 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32005247 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 6736028 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24780610 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 16803575 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21194254 | ||
| Pubmed | The adult beta-globin genes of the "single" type mouse C57BL. | 2.28e-06 | 2 | 53 | 2 | 7237554 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 18603555 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 264241 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11418464 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 27245334 | ||
| Pubmed | Co-inheritance of alpha- and beta-thalassaemia in mice ameliorates thalassaemic phenotype. | 2.28e-06 | 2 | 53 | 2 | 17493845 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 28641125 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 8524813 | ||
| Pubmed | Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S. | 2.28e-06 | 2 | 53 | 2 | 21304105 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25616571 | ||
| Pubmed | In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. | 2.28e-06 | 2 | 53 | 2 | 30422819 | |
| Pubmed | β-Globin cis-elements determine differential nuclear targeting through epigenetic modifications. | 2.28e-06 | 2 | 53 | 2 | 24297746 | |
| Pubmed | Cloning and amplification of alpha and beta mouse globin gene sequences synthesised in vitro. | 2.28e-06 | 2 | 53 | 2 | 338418 | |
| Pubmed | Nephrectomy Does not Exacerbate Cancellous Bone loss in Thalassemic Mice. | 2.28e-06 | 2 | 53 | 2 | 32385316 | |
| Pubmed | The evolution and sequence comparison of two recently diverged mouse chromosomal beta--globin genes. | 2.28e-06 | 2 | 53 | 2 | 519759 | |
| Pubmed | Genetic alterations in members of the Wnt pathway in acute leukemia. | 2.28e-06 | 2 | 53 | 2 | 21902576 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23074246 | ||
| Pubmed | Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation. | 2.28e-06 | 2 | 53 | 2 | 16421096 | |
| Pubmed | High phosphate intake induces bone loss in nephrectomized thalassemic mice. | 2.28e-06 | 2 | 53 | 2 | 35622784 | |
| Pubmed | A humanized mouse model for a common beta0-thalassemia mutation. | 2.28e-06 | 2 | 53 | 2 | 15780748 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 7935410 | ||
| Pubmed | Evolution of the mouse beta-globin genes: a recent gene conversion in the Hbbs haplotype. | 2.28e-06 | 2 | 53 | 2 | 3870864 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11877258 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 11860449 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 3428512 | ||
| Pubmed | Structural basis of the Axin-adenomatous polyposis coli interaction. | 2.28e-06 | 2 | 53 | 2 | 10811618 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 1820025 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22767512 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15820143 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 3620470 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 12127975 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 569555 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24817273 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 8041612 | ||
| Pubmed | A 66-base pair insert bridges the deletion responsible for a mouse model of beta-thalassemia. | 2.28e-06 | 2 | 53 | 2 | 3017971 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33822774 | ||
| Pubmed | Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model. | 2.28e-06 | 2 | 53 | 2 | 27959920 | |
| Pubmed | Intervening sequence of DNA identified in the structural portion of a mouse beta-globin gene. | 2.28e-06 | 2 | 53 | 2 | 273235 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 999642 | ||
| Pubmed | Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia. | 2.28e-06 | 2 | 53 | 2 | 22427201 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 35396390 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32745462 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 36214153 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 728996 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 14615383 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23157711 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19609526 | ||
| Pubmed | Discovery of a new HBB haplotype w2 in a wild-derived house mouse, Mus musculus. | 2.28e-06 | 2 | 53 | 2 | 18299925 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 10359765 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 19675095 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 2991851 | ||
| Pubmed | 3.35e-06 | 268 | 53 | 6 | 33640491 | ||
| Pubmed | A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression. | 6.83e-06 | 3 | 53 | 2 | 21281810 | |
| Pubmed | CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants. | 6.83e-06 | 3 | 53 | 2 | 23525311 | |
| Pubmed | An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. | 6.83e-06 | 3 | 53 | 2 | 17607360 | |
| Pubmed | Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice. | 6.83e-06 | 3 | 53 | 2 | 28151426 | |
| Pubmed | Oxygen affinity of hemoglobin regulates O2 consumption, metabolism, and physical activity. | 6.83e-06 | 3 | 53 | 2 | 12458204 | |
| Pubmed | In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. | 6.83e-06 | 3 | 53 | 2 | 10079113 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22461476 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 7357610 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 37256933 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 19734452 | ||
| Pubmed | Insights into hemoglobin assembly through in vivo mutagenesis of α-hemoglobin stabilizing protein. | 6.83e-06 | 3 | 53 | 2 | 22287545 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 31723073 | ||
| Pubmed | NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice. | 6.83e-06 | 3 | 53 | 2 | 32107334 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 277329 | ||
| Pubmed | Reversal of lethal alpha- and beta-thalassemias in mice by expression of human embryonic globins. | 6.83e-06 | 3 | 53 | 2 | 9787139 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 26276665 | ||
| Pubmed | Hemoglobin is present as a canonical α2β2 tetramer in dopaminergic neurons. | 6.83e-06 | 3 | 53 | 2 | 23685348 | |
| Pubmed | AXIN1 Expression and Localization in Meningiomas and Association to Changes of APC and E-cadherin. | 6.83e-06 | 3 | 53 | 2 | 27630299 | |
| Pubmed | Antisickling effects of an endogenous human alpha-like globin. | 6.83e-06 | 3 | 53 | 2 | 15034572 | |
| Pubmed | A mechanism for Ikaros regulation of human globin gene switching. | 6.83e-06 | 3 | 53 | 2 | 18318763 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 23975182 | ||
| Pubmed | Complex signatures of selection and gene conversion in the duplicated globin genes of house mice. | 6.83e-06 | 3 | 53 | 2 | 17660536 | |
| Pubmed | The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry. | 6.83e-06 | 3 | 53 | 2 | 34002695 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 15981102 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 33830076 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 24722208 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 16716198 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 33941818 | ||
| Interaction | CLEC11A interactions | 5.29e-06 | 96 | 53 | 5 | int:CLEC11A | |
| GeneFamily | Hemoglobin subunits | 2.23e-04 | 10 | 41 | 2 | 940 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.37e-04 | 181 | 41 | 4 | 694 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.96e-03 | 29 | 41 | 2 | 396 | |
| GeneFamily | Collagens | 4.88e-03 | 46 | 41 | 2 | 490 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.27e-03 | 718 | 41 | 6 | 28 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.43e-03 | 53 | 41 | 2 | 532 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP | 2.69e-06 | 195 | 53 | 6 | M4201 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.03e-06 | 171 | 54 | 5 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 184 | 54 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 194 | 54 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-06 | 197 | 54 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-06 | 198 | 54 | 5 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 2.52e-05 | 140 | 54 | 4 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-05 | 145 | 54 | 4 | a6c291811bf62f1c13f1b4b396d75c2223cf1c7d | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 2.89e-05 | 145 | 54 | 4 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.97e-05 | 146 | 54 | 4 | 03a6a442f1f6d173a41aeebbfe41ee08853d9585 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.28e-05 | 177 | 54 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 178 | 54 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 6.70e-05 | 180 | 54 | 4 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.85e-05 | 181 | 54 | 4 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 6.85e-05 | 181 | 54 | 4 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-05 | 181 | 54 | 4 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-05 | 182 | 54 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 7.15e-05 | 183 | 54 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 183 | 54 | 4 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.30e-05 | 184 | 54 | 4 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.45e-05 | 185 | 54 | 4 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 185 | 54 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 189 | 54 | 4 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 189 | 54 | 4 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 189 | 54 | 4 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.26e-05 | 190 | 54 | 4 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.26e-05 | 190 | 54 | 4 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | severe_COVID-19|World / disease group, cell group and cell class (v2) | 8.78e-05 | 193 | 54 | 4 | 9012cadd138be775fb167a5bc895e512619f8a95 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.78e-05 | 193 | 54 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.78e-05 | 193 | 54 | 4 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 194 | 54 | 4 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.13e-05 | 195 | 54 | 4 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 195 | 54 | 4 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.32e-05 | 196 | 54 | 4 | 9afd0a7135028a446f06bb68f334e79b8f171b45 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.50e-05 | 197 | 54 | 4 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | COVID-19_Severe-PLT_5|World / Disease Group and Platelet Clusters | 9.88e-05 | 199 | 54 | 4 | 937e4028f896bc6b751182517611825d6716c682 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-04 | 200 | 54 | 4 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.01e-04 | 200 | 54 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-04 | 200 | 54 | 4 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-hematologic-erythrocytic-erythroid_lineage_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-04 | 116 | 54 | 3 | a080b3bba1f5ae714faef121ace1011c864eca8a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.16e-04 | 120 | 54 | 3 | a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a | |
| ToppCell | Mild-Myeloid-Macrophages-|Mild / Condition, Lineage, Cell class and cell subclass | 4.36e-04 | 122 | 54 | 3 | b837456a6a236add2c0005cb3ca71568d631014e | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-04 | 133 | 54 | 3 | 386c9bbd9bab62209a67ebae6cd6ac0d7cef0a2d | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.51e-04 | 140 | 54 | 3 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.51e-04 | 140 | 54 | 3 | 0e1e9281de87df178ac41ed6b697b4fa09be2749 | |
| ToppCell | critical-Lymphoid-NKT|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.93e-04 | 143 | 54 | 3 | dca035bfbfd1665c04076c43da8bc18a1502b9de | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 7.35e-04 | 146 | 54 | 3 | 1cb2e157222631e8915d89b255a843d16d7d99cc | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-04 | 147 | 54 | 3 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-04 | 147 | 54 | 3 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 7.80e-04 | 149 | 54 | 3 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.80e-04 | 149 | 54 | 3 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 7.95e-04 | 150 | 54 | 3 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | mild-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.95e-04 | 150 | 54 | 3 | 979566663d1110475f1e017c2f9890aca4b6f701 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.95e-04 | 150 | 54 | 3 | 6bdf9df586f348641a25a445e83a41e47e7f347e | |
| ToppCell | Severe_COVID-19-undefined|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.11e-04 | 151 | 54 | 3 | 2ae403417fcb3fe402f6f47bb60ffa68d5fefd2a | |
| ToppCell | Severe_COVID-19-undefined-undefined|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 8.11e-04 | 151 | 54 | 3 | b402185dd7a93c6d0ec5c4d84d5031a157ee8cfb | |
| ToppCell | Healthy_donor-B_cell|Healthy_donor / disease group, cell group and cell class (v2) | 8.26e-04 | 152 | 54 | 3 | 5768edfde8010324d8594815e73bbfba2c3045f3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.26e-04 | 152 | 54 | 3 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.58e-04 | 154 | 54 | 3 | 6c1e7682c43c40b58b371c58deb10b839700ebcc | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.91e-04 | 156 | 54 | 3 | 1a0e081284a99c1b345990775015b8a2fa469496 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.91e-04 | 156 | 54 | 3 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.24e-04 | 158 | 54 | 3 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 9.58e-04 | 160 | 54 | 3 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.58e-04 | 160 | 54 | 3 | 529034a1101d7772d82f86beb5c6fa9c9dd97067 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.58e-04 | 160 | 54 | 3 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.93e-04 | 162 | 54 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.93e-04 | 162 | 54 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 163 | 54 | 3 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-03 | 163 | 54 | 3 | 9195051d6bcdd450ed745a099828a0d76d9d3f0b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-03 | 163 | 54 | 3 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | Control-APC-like-Monocytes|Control / group, cell type (main and fine annotations) | 1.01e-03 | 163 | 54 | 3 | 4bc80a2c741d462724b6f3902377d48c57478932 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-03 | 164 | 54 | 3 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-03 | 165 | 54 | 3 | 35a6de30438de364ccca948fc932da541a69ef89 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-03 | 167 | 54 | 3 | ecdbfde870a2a44c44b9dd65a8737afc6fbf816c | |
| ToppCell | BAL-Severe-undefined-undefined-undefined|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-03 | 168 | 54 | 3 | 5a1121cc268720d1c0a243e2faab5cf011c20a83 | |
| ToppCell | BAL-Severe-undefined-undefined-undefined-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-03 | 168 | 54 | 3 | 15df45e053657150f7b188e407e946571745c09e | |
| ToppCell | BAL-Severe-undefined-undefined|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-03 | 168 | 54 | 3 | 460dcefbd3d9eb1064986cd66b2ca4b1408ba87d | |
| ToppCell | BAL-Severe-undefined-undefined|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-03 | 168 | 54 | 3 | cb5fccac64bfea18d5607fb232e024d1f7149450 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 1.10e-03 | 168 | 54 | 3 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | BAL-Severe-undefined|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-03 | 168 | 54 | 3 | 5bf0a389d9813cc9d87afc8d003c20f028cda902 | |
| ToppCell | BAL-Severe-undefined|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-03 | 168 | 54 | 3 | 93f77a6cad04d14bfa01bb98ff169f668a6ad659 | |
| ToppCell | BAL-Severe-undefined-undefined-undefined-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-03 | 168 | 54 | 3 | b020f371e70b4ac60e7027a359e3195611c8ed33 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.10e-03 | 168 | 54 | 3 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | BAL-Severe-undefined-undefined-undefined|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-03 | 168 | 54 | 3 | 5d8ef76247c0afa9b196ebc5665228b026c49b30 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-03 | 169 | 54 | 3 | 6a2ef66d7ff69a92e8c62759482e823a07352440 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-03 | 169 | 54 | 3 | 6ff1172da690ca17f7108f1617b255b766971a57 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.12e-03 | 169 | 54 | 3 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 170 | 54 | 3 | 6e82e41acd1299aa549a32ac036b39754abdf376 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 170 | 54 | 3 | 18cd941bf3ca7cc0b6af1317bd2619d283353de0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-03 | 170 | 54 | 3 | b5b47fe42617a4c2ebb49c8ed55db3926213a75a | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-03 | 171 | 54 | 3 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-03 | 173 | 54 | 3 | ef8d720b99470fe1953661f6e66bc0366266bdb6 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-03 | 173 | 54 | 3 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-03 | 173 | 54 | 3 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.20e-03 | 173 | 54 | 3 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 1.20e-03 | 173 | 54 | 3 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| Drug | tricapryl(methyl)ammonium | 5.32e-06 | 2 | 53 | 2 | CID011071504 | |
| Drug | allyl 2,4,6-tribromophenyl ether | 5.32e-06 | 2 | 53 | 2 | CID000076767 | |
| Drug | 1,3,5-tribromobenzene | 5.32e-06 | 2 | 53 | 2 | CID000012279 | |
| Drug | AC1L3OJQ | 5.32e-06 | 2 | 53 | 2 | CID000119294 | |
| Drug | pentabromobenzene | 5.32e-06 | 2 | 53 | 2 | CID000011854 | |
| Drug | tribromobenzene | 5.32e-06 | 2 | 53 | 2 | CID000011842 | |
| Drug | Bromkal 73-5 PE | 5.32e-06 | 2 | 53 | 2 | CID000118216 | |
| Drug | 2-(alpha-hydroxybenzyl)-benzimidazole | 5.32e-06 | 2 | 53 | 2 | CID000005792 | |
| Drug | NSC-334295 | 5.32e-06 | 2 | 53 | 2 | CID000100107 | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 6.18e-06 | 196 | 53 | 6 | 5505_DN | |
| Drug | 1w22 | 9.48e-06 | 18 | 53 | 3 | CID000449096 | |
| Drug | magnesium acetate tetrahydrate | 1.32e-05 | 20 | 53 | 3 | CID000134717 | |
| Drug | furyl-dihydropyridine I | 1.59e-05 | 3 | 53 | 2 | CID000125806 | |
| Drug | Nx-D | 1.59e-05 | 3 | 53 | 2 | CID006914638 | |
| Drug | mer13 | 1.59e-05 | 3 | 53 | 2 | CID000107453 | |
| Drug | BTBPE | 1.59e-05 | 3 | 53 | 2 | CID000037840 | |
| Drug | pentabromoethylbenzene | 1.59e-05 | 3 | 53 | 2 | CID000006800 | |
| Drug | AC1L4CDO | 3.18e-05 | 4 | 53 | 2 | CID000154482 | |
| Drug | HPED | 3.18e-05 | 4 | 53 | 2 | CID000125856 | |
| Drug | PTU-23 | 3.18e-05 | 4 | 53 | 2 | CID000853760 | |
| Drug | AC1L9JVG | 3.18e-05 | 4 | 53 | 2 | CID000446603 | |
| Drug | 4-(2-carboxyvinyl)benzoic acid | 3.18e-05 | 4 | 53 | 2 | CID000089196 | |
| Drug | 1,4-dibromobenzene | 3.18e-05 | 4 | 53 | 2 | CID000007804 | |
| Drug | 1,2,4,5-tetrabromobenzene | 3.18e-05 | 4 | 53 | 2 | CID000012486 | |
| Drug | tallimustine | 3.35e-05 | 27 | 53 | 3 | CID000065924 | |
| Drug | urobilinogen | 3.74e-05 | 28 | 53 | 3 | CID000026818 | |
| Drug | AC1L8TD7 | 5.29e-05 | 5 | 53 | 2 | CID000407802 | |
| Drug | arildone | 5.29e-05 | 5 | 53 | 2 | CID000041782 | |
| Drug | 1,2,4-tribromobenzene | 5.29e-05 | 5 | 53 | 2 | CID000012002 | |
| Drug | CaBr2 | 5.29e-05 | 5 | 53 | 2 | CID000024608 | |
| Drug | Hexbbp | 5.29e-05 | 5 | 53 | 2 | CID000119134 | |
| Drug | 2,4-pentanediol | 7.93e-05 | 6 | 53 | 2 | CID000012262 | |
| Drug | pentabromotoluene | 7.93e-05 | 6 | 53 | 2 | CID000006906 | |
| Drug | AC1LDLU6 | 7.93e-05 | 6 | 53 | 2 | CID000620919 | |
| Drug | BP-6 | 8.75e-05 | 37 | 53 | 3 | CID000446948 | |
| Drug | glycidamide | 9.39e-05 | 102 | 53 | 4 | CID000091550 | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 4729_UP | |
| Drug | Cytisine (-) [485-35-8]; Up 200; 21uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 5739_UP | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 6698_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; PC3; HG-U133A | 9.67e-05 | 198 | 53 | 5 | 1945_UP | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 3766_UP | |
| Drug | uric acid | 9.90e-05 | 199 | 53 | 5 | CID000001175 | |
| Drug | flourish | 1.03e-04 | 39 | 53 | 3 | CID000009291 | |
| Drug | medrylamine | 1.11e-04 | 7 | 53 | 2 | CID000010669 | |
| Drug | purpald | 1.11e-04 | 7 | 53 | 2 | CID002723946 | |
| Drug | HBBA | 1.11e-04 | 7 | 53 | 2 | CID016072199 | |
| Drug | SV-4814 | 1.11e-04 | 7 | 53 | 2 | CID003010509 | |
| Drug | Viroxime | 1.11e-04 | 7 | 53 | 2 | CID000051567 | |
| Drug | trimesic acid | 1.11e-04 | 7 | 53 | 2 | CID000011138 | |
| Drug | 4-nitrosobiphenyl | 1.11e-04 | 7 | 53 | 2 | CID000024971 | |
| Drug | AC1L2B9U | 1.48e-04 | 8 | 53 | 2 | CID000044164 | |
| Drug | L 35 | 1.48e-04 | 8 | 53 | 2 | CID000195347 | |
| Drug | P-15 | 1.65e-04 | 222 | 53 | 5 | CID000200884 | |
| Drug | flavins | 1.88e-04 | 122 | 53 | 4 | CID005326566 | |
| Drug | 4-sulfophenyl isothiocyanate | 1.89e-04 | 9 | 53 | 2 | CID000087189 | |
| Drug | N,N-diethylphenylacetamide | 1.89e-04 | 9 | 53 | 2 | CID000017076 | |
| Drug | OP-2507 | 1.89e-04 | 9 | 53 | 2 | CID006438365 | |
| Drug | 3H-AMT | 1.89e-04 | 9 | 53 | 2 | CID000107680 | |
| Drug | AC1L252K | 1.89e-04 | 9 | 53 | 2 | CID000015061 | |
| Drug | HS 4 | 2.36e-04 | 10 | 53 | 2 | CID005493398 | |
| Drug | decabromodiphenyl | 2.36e-04 | 10 | 53 | 2 | CID000026164 | |
| Drug | ferrous succinate | 2.36e-04 | 10 | 53 | 2 | CID000159252 | |
| Drug | 1-butyl-3-methylimidazolium hexafluorophosphate | 2.36e-04 | 10 | 53 | 2 | CID002734174 | |
| Drug | AC1LADZE | 2.36e-04 | 10 | 53 | 2 | CID000486298 | |
| Drug | hexabromobenzene | 2.36e-04 | 10 | 53 | 2 | CID000006905 | |
| Drug | 1q65 | 2.72e-04 | 54 | 53 | 3 | CID000448017 | |
| Drug | TTAB | 2.89e-04 | 11 | 53 | 2 | CID000014250 | |
| Drug | syntometrine | 2.89e-04 | 11 | 53 | 2 | CID011979741 | |
| Drug | 2,6-dihydroxyacetophenone | 2.89e-04 | 11 | 53 | 2 | CID000069687 | |
| Drug | NFPLP | 2.89e-04 | 11 | 53 | 2 | CID006451852 | |
| Drug | N-(2-hydroxypropyl)valine | 2.89e-04 | 11 | 53 | 2 | CID000130204 | |
| Drug | 4-dimethylaminophenol | 2.89e-04 | 11 | 53 | 2 | CID000022173 | |
| Drug | potassium ferricyanide | 3.03e-04 | 56 | 53 | 3 | CID000026250 | |
| Drug | alpha-hydroxybutyrate | 3.03e-04 | 56 | 53 | 3 | CID000011266 | |
| Drug | sulfur dioxide | 3.36e-04 | 58 | 53 | 3 | CID000001119 | |
| Drug | 2-hydroxylamino-5-ethyl-5-propylbarbituric acid | 3.46e-04 | 12 | 53 | 2 | CID000128182 | |
| Drug | Ferastral | 3.46e-04 | 12 | 53 | 2 | CID000171553 | |
| Drug | 7-methylguanosine 5'-phosphate | 3.46e-04 | 12 | 53 | 2 | CID000440190 | |
| Drug | silver fluoride | 3.46e-04 | 12 | 53 | 2 | CID000062656 | |
| Drug | 3-methacryloxypropyltrimethoxysilane | 3.46e-04 | 12 | 53 | 2 | CID000017318 | |
| Drug | p-nitrophenacyl bromide | 3.46e-04 | 12 | 53 | 2 | CID000066840 | |
| Drug | Hb Q | 3.46e-04 | 12 | 53 | 2 | CID000154048 | |
| Drug | thioxoboron | 3.53e-04 | 59 | 53 | 3 | CID006327264 | |
| Drug | bendazac | 4.08e-04 | 13 | 53 | 2 | CID000002313 | |
| Drug | pentafluorophenyl isothiocyanate | 4.08e-04 | 13 | 53 | 2 | CID000123452 | |
| Drug | ketononestrol aziridine | 4.08e-04 | 13 | 53 | 2 | CID000130642 | |
| Drug | 3-aminobiphenyl | 4.08e-04 | 13 | 53 | 2 | CID000016717 | |
| Drug | AC1O4686 | 4.08e-04 | 13 | 53 | 2 | CID006379235 | |
| Drug | (N5,C4a)-(Alpha-Hydroxy-Propano)-3,4,4a,5-Tetrahydro-Flavin-Adenine Dinucleotide | 4.08e-04 | 13 | 53 | 2 | CID005494420 | |
| Drug | 3-mercaptolactic acid | 4.08e-04 | 13 | 53 | 2 | CID000160645 | |
| Drug | sodium ferric gluconate | 4.08e-04 | 13 | 53 | 2 | CID011254352 | |
| Drug | crystal violet | 4.29e-04 | 63 | 53 | 3 | CID000003468 | |
| Drug | HS 3 | 4.75e-04 | 14 | 53 | 2 | CID003060736 | |
| Drug | S-7HNa | 4.75e-04 | 14 | 53 | 2 | CID000188208 | |
| Drug | 6-amino-m-cresol | 4.75e-04 | 14 | 53 | 2 | CID000076082 | |
| Drug | AC1L5F7F | 4.91e-04 | 66 | 53 | 3 | CID000227041 | |
| Drug | E 64 | 5.39e-04 | 161 | 53 | 4 | CID000123985 | |
| Drug | diacetyldeuteroheme | 5.48e-04 | 15 | 53 | 2 | CID004629150 | |
| Drug | PBBs | 5.48e-04 | 15 | 53 | 2 | CID000158629 | |
| Drug | PD 128907 | 5.48e-04 | 15 | 53 | 2 | CID000005117 | |
| Disease | Delta-Beta Thalassemia | 9.13e-06 | 3 | 52 | 2 | C0271985 | |
| Disease | beta thalassemia (implicated_via_orthology) | 9.13e-06 | 3 | 52 | 2 | DOID:12241 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.30e-05 | 447 | 52 | 7 | C3714756 | |
| Disease | Chloracne | 2.71e-05 | 33 | 52 | 3 | C0263454 | |
| Disease | hemoglobin measurement, hemoglobin A2 measurement | 3.04e-05 | 5 | 52 | 2 | EFO_0004509, EFO_0005845 | |
| Disease | hemoglobin E disease | 4.55e-05 | 6 | 52 | 2 | MONDO_0016243 | |
| Disease | Hepatoblastoma | 4.55e-05 | 6 | 52 | 2 | C0206624 | |
| Disease | anemia (biomarker_via_orthology) | 6.36e-05 | 7 | 52 | 2 | DOID:2355 (biomarker_via_orthology) | |
| Disease | HEPATOCELLULAR CARCINOMA | 1.09e-04 | 9 | 52 | 2 | 114550 | |
| Disease | response to tamoxifen | 1.09e-04 | 9 | 52 | 2 | EFO_0009391 | |
| Disease | Hepatocellular carcinoma | 1.09e-04 | 9 | 52 | 2 | cv:C2239176 | |
| Disease | anemia (implicated_via_orthology) | 3.15e-04 | 15 | 52 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Tourette syndrome, schizophrenia | 4.58e-04 | 18 | 52 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | cortical surface area measurement | 5.18e-04 | 1345 | 52 | 9 | EFO_0010736 | |
| Disease | Adenocarcinoma of large intestine | 6.57e-04 | 96 | 52 | 3 | C1319315 | |
| Disease | Splenomegaly | 6.88e-04 | 22 | 52 | 2 | C0038002 | |
| Disease | Vitiligo | 7.62e-04 | 101 | 52 | 3 | EFO_0004208 | |
| Disease | blood urea nitrogen measurement | 1.19e-03 | 452 | 52 | 5 | EFO_0004741 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLQAKMGKGGDAASH | 746 | Q8NAT2 | |
| MLPPGAQHSDEKGAK | 301 | P55196 | |
| TKAGHPPAVKAGGMR | 11 | P51397 | |
| KEKPLHMPGGDGHRG | 486 | P48751 | |
| MPNSERHGGKKDGSG | 1 | Q9NYV4 | |
| EGGPKAMGGDHQKAD | 701 | Q02952 | |
| KKAHPNMEAGPPESG | 86 | P49662 | |
| AKGEGPDVHMTLPKG | 641 | Q09666 | |
| HRDPGNKAGMTSLPG | 181 | Q9BZ11 | |
| LKPKGPHSQEGDTLM | 261 | O60403 | |
| QMGKGGKHHLGLEEP | 201 | P18065 | |
| PKGDKGEQGDQGPRM | 151 | Q9BXS0 | |
| LGNGPSLMKGNSDKP | 981 | Q9P2S2 | |
| DPGLPAKKAGMQAGD | 361 | Q86UT5 | |
| GGEDPGKPSDAMLKN | 91 | Q8IZ21 | |
| AGGPAPAGAAKMKVV | 16 | Q9UJJ9 | |
| KPGKDPGDQDGAAMD | 11 | Q9NYX4 | |
| KMPVALGGAASGHGK | 501 | O15169 | |
| ASPMPGAKEAGQGKD | 1901 | Q3T8J9 | |
| SPGKAHDGAKGDMGL | 681 | Q8IZC6 | |
| GKSHDQAPGLPKGMD | 366 | Q8N7U6 | |
| GTGMHAPGEKGNLAA | 251 | Q86Z14 | |
| SPDAVMGNPKVKAHG | 51 | P02042 | |
| TPDAVMGNPKVKAHG | 51 | P68871 | |
| HKKGPMETGLFPGSN | 181 | Q9H825 | |
| GGNKKPLHADMDTNG | 431 | Q8N108 | |
| KMKAQAAEPNRGGPG | 371 | Q9Y6J9 | |
| KGEAMQKLPGTSHGG | 726 | A6NHR9 | |
| KKLNGMGDDGSPPAK | 16 | P12757 | |
| MKAGKPVVAAPGAGN | 1166 | Q7Z7B0 | |
| MTAQPGPGHGKKLGH | 46 | O60331 | |
| MANGKPGDPKSALHR | 46 | P79522 | |
| MSDAGGGKKPPVDPQ | 1 | Q10587 | |
| TKTMDPGPGGLDTDH | 431 | Q5T8A7 | |
| SGKPGESGMPEEHNA | 2256 | Q13023 | |
| GASVHNAMQLKPGKP | 101 | P54922 | |
| LKGDNEKHSPRNMGG | 2056 | P25054 | |
| MEAPAQKAGQGGLPK | 1 | Q96EG3 | |
| LGNEAGAGAMSHPKP | 431 | Q96PV4 | |
| AMDDKPGVSGQLPKG | 251 | Q9ULJ3 | |
| GLEKPPGATMMGQEH | 1476 | Q8IWN7 | |
| GGSNKPQHMAEEGPG | 1131 | O15015 | |
| MSGPGLAEPKADSHK | 1701 | Q5JSZ5 | |
| SSDGLPNKGMELKHG | 1166 | Q9UGU0 | |
| HDPDPGPGGQKMSLS | 21 | O75865 | |
| LADPPSMKVHGVDGG | 941 | O15090 | |
| LSAEGGDKALHKMGP | 566 | A7E2V4 | |
| LMDLHGKGPTGEKPF | 351 | P51815 | |
| PDGHAKKMRPGEATL | 396 | P57081 | |
| DLHPGGPSKLMLAAG | 116 | P51687 | |
| PGKMSPKHDGLGTAD | 151 | Q5CZA5 | |
| DSQLKHGAPRPGMKS | 1271 | Q70EL1 | |
| PEKGNIKAGPNMNHS | 796 | Q96CT2 | |
| GKLKGETMDLQHGSP | 56 | Q6ZMR3 |